Xiao-Kun Zhang Selected Research

Xiao-Kun Zhang Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 07/2004
6	Lung Neoplasms (Lung Cancer) 01/2021 - 04/2008
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 03/2010
4	Liver Neoplasms (Liver Cancer) 01/2014 - 04/2008
3	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 05/2018 - 05/2007
3	Leukemia 04/2014 - 05/2007
2	Triple Negative Breast Neoplasms 01/2024 - 09/2023
2	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2021
2	Carcinogenesis 01/2021 - 09/2015
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2011
2	Acute Promyelocytic Leukemia 10/2020 - 02/2017
2	Inflammation (Inflammations) 09/2019 - 04/2017
1	Carcinoma (Carcinomatosis) 01/2024
1	Melanoma (Melanoma, Malignant) 01/2024
1	Tics (Tic) 09/2023
1	Adenocarcinoma 01/2023
1	Hyperplasia 12/2022
1	Non-alcoholic Fatty Liver Disease 07/2022
1	Fibrosis (Cirrhosis) 07/2022
1	Postmenopausal Osteoporosis 02/2021
1	Endometrial Hyperplasia 02/2021
1	Osteoporosis 02/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Amyloid Plaque 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2018

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2008
6	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023 - 05/2007
6	LigandsIBA 02/2021 - 02/2013
5	RetinoidsIBA 01/2020 - 07/2004
5	Retinoid X Receptor alphaIBA 01/2019 - 10/2006
5	Cardiac GlycosidesIBA 01/2019 - 09/2013
4	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2020 - 04/2008
4	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2020 - 07/2004
3	Peptides (Polypeptides)IBA 01/2024 - 05/2018
3	K-80003IBA 01/2019 - 06/2010
3	4- (3- (1- adamantyl)- 4- hydroxyphenyl)- 3- chlorocinnamic acidIBA 01/2019 - 05/2007
3	Orphan Nuclear ReceptorsIBA 01/2016 - 09/2008
2	matriptaseIBA 03/2024 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 12/2022
2	celastrolIBA 09/2019 - 04/2017
2	TriterpenesIBA 09/2019 - 04/2017
2	DigoxigeninIBA 02/2018 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 02/2018 - 01/2017
2	Retinoic Acid Receptor gammaIBA 01/2017 - 03/2010
2	CarcinogensIBA 01/2017 - 01/2011
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017 - 01/2013
2	cytosporone BIBA 02/2016 - 02/2013
2	Furocoumarins (Furanocoumarins)IBA 12/2014 - 07/2011
2	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2014 - 01/2011
2	Hydroxyl RadicalIBA 02/2013 - 09/2008
2	AcidsIBA 09/2008 - 07/2004
1	Epidermal Growth Factor (EGF)IBA 03/2024
1	Peptide Hydrolases (Proteases)FDA Link 03/2024
1	Adenosine Triphosphate (ATP)IBA 01/2024
1	ciforadenantIBA 01/2024
1	Adenosine (Adenocard)FDA LinkGeneric 01/2024
1	AntigensIBA 01/2024
1	LipidsIBA 01/2024
1	MicellesIBA 01/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2023
1	anoplinIBA 09/2023
1	graphene oxideIBA 09/2023
1	Nanoparticle Drug Delivery SystemIBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Glucagon Receptors (Glucagon Receptor)IBA 12/2022
1	Glucagon (Glukagon)FDA Link 12/2022
1	Alanine Transaminase (SGPT)IBA 07/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022
1	pien tze huangIBA 07/2022
1	Estrogens (Estrogen)FDA Link 02/2021
1	Estrogen Receptor alphaIBA 02/2021
1	norlichexanthoneIBA 02/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	CardenolidesIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	GlycosidesIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Rosiglitazone (Avandia)FDA Link 10/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	tideglusibIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Bexarotene (LGD1069)FDA Link 01/2019
1	Serine Proteases (Serine Protease)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	BI1071IBA 01/2019
1	Sulindac (Copal)FDA LinkGeneric 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2018
1	Mesylates (Mesylate)IBA 05/2018
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 04/2017

Therapy/Procedure

5	Therapeutics 02/2021 - 01/2016
2	Immunotherapy 01/2024 - 09/2023
1	Photothermal Therapy 09/2023
1	Chemoradiotherapy 01/2021
1	Drug Therapy (Chemotherapy) 05/2018